chapter 1 The Pathophysiology of Graft-vs.-Host Disease -- chapter 2 Animal Models of Graft-vs.-Host Disease -- chapter 3 Graft-vs.-Host Disease as a Th1-Type Process: Regulation by Th2-Type Cells -- chapter 4 Role of T-Cell Costimulation and Regulatory Cells in Allogeneic Hematopoietic Cell Transplantation -- chapter 5 Chemokines and Graft-vs.-Host Disease -- chapter 6 Graft-vs.-Leukemia Effects -- chapter 7 The Immune System in Graft-vs.-Host Disease: Target and Effector Organ -- chapter 8 Pathology and Pathogenesis of Cutaneous Graft-vs.-Host Disease -- chapter 9 Graft-vs.-Host Disease of the Liver -- chapter 10 Intestinal Graft-vs.-Host Disease -- chapter 11 The Pathophysiology of Lung Injury After Hematopoietic Stem Cell Transplantation -- chapter 12 Clinical Spectrum of Acute Graft-vs.-Host Disease -- chapter 13 Role of Minor Histocompatibility Antigens in the Development of Graft-vs.-Host Disease and Graft-vs.-Leukemia Reactivity -- chapter 14 Advances in Tissue Typing and Their Potential Impact on GVHD Incidence and Severity -- chapter 15 Immunosuppression and Immunophilin Ligands: Cyclosporin, Tacrolimus, and Sirolimus -- chapter 16 Prophylaxis and Treatment of Acute Graft-vs.-Host Disease -- chapter 17 Graft Manipulation to Prevent Graft-vs.-Host Disease -- chapter 18 Graft-vs.-Host Disease in Nonmyeloablative Transplant -- chapter 19 Adoptive Immunotherapy in Stem Cell Transplantation -- chapter 20 Clinical Spectrum and Therapeutic Approaches to Chronic Graft-vs.-Host Disease -- chapter 21 Recent Advances and Future Directions.